导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 48.18% | 63/1050 |
| 近一周 | 5.54% | 22/1104 |
| 近一月 | -3.98% | 330/1103 |
| 近一季 | -4.83% | 414/1094 |
| 近半年 | 40.51% | 60/1074 |
| 近一年 | 45.00% | 92/1020 |
| 近两年 | 147.33% | 113/926 |
| 近三年 | 113.95% | 83/834 |
| 成立以来 | 69.30% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.75% 427/1070 |
74.78% 132/1101 |
- - |
- - |
| 2025 | 31.74% 445/1065 |
9.26% 174/1014 |
0.91% 622/1038 |
30.58% 348/1050 |
-8.50% 846/1065 |
| 2024 | 6.23% 388/1011 |
-8.96% 740/960 |
-0.87% 367/983 |
13.81% 318/991 |
3.42% 185/1011 |
| 2023 | -2.40% 145/952 |
3.94% 376/880 |
-2.39% 333/895 |
-7.35% 458/915 |
3.83% 32/952 |
| 2022 | -24.86% 491/867 |
-18.09% 433/773 |
1.02% 678/806 |
-12.76% 444/845 |
4.10% 241/867 |
| 2021 | 13.11% 206/740 |
-6.92% 414/580 |
20.58% 155/659 |
-8.70% 470/704 |
10.38% 77/740 |
| 2020 | 37.71% 312/554 |
-8.43% 363/419 |
15.12% 350/466 |
11.89% 205/517 |
16.75% 172/554 |
| 2019 | 37.14% 240/410 |
25.03% 701/1146 |
-1.65% 497/1228 |
3.47% 234/390 |
7.78% 246/410 |
| 2018 | -19.93% 79/349 |
- - |
-4.95% 183/990 |
-2.73% 354/1000 |
-7.27% 120/1080 |
| 2017 | 14.50% 114/285 |
- - |
- - |
- - |
- - |
| 2016 | -13.24% 82/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 鹏华改革红利股票 VS. 东吴新产业精选股票A(580008) |